China has announced targeted measures restricting European Union medical device imports in government procurement, describing the move as a "necessary response" to protect national interests and ensure fair market competition. The decision follows heightened trade tensions between Beijing and Brussels over industrial policies.
A Chinese Commerce Ministry spokesperson stated Sunday that the measures apply exclusively to medical equipment purchased through government tenders, emphasizing that European-funded manufacturers operating within China will face no operational disruptions. "We remain committed to providing a stable business environment for all enterprises," the spokesperson said during a regular briefing.
Analysts suggest the measures could reshape medical supply chains as governments worldwide increasingly prioritize domestic healthcare security. The announcement comes amid ongoing EU reviews of Chinese subsidies in green technology sectors. Market observers note that Germany’s €14 billion medical device export sector to China may face immediate impacts, while joint ventures in Shanghai and Shenzhen continue normal production.
This development underscores the delicate balance between economic interdependence and strategic competition in global trade frameworks. Business leaders are advised to monitor evolving procurement guidelines as both economic powers navigate complex negotiation landscapes.
